Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1996-07-23
1999-06-22
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424465, 424682, A61K 920
Patent
active
059141298
ABSTRACT:
Magnesium-containing analgesic compositions used for the alleviation of pain, in particular, migraine headache pain, and methods for using the same are described herein. The compositions consist essentially of an analgesic agent, a magnesium salt, a stimulant, optionally an effervescing agent, and a pharmacetically acceptable carrier or vehicle. The symptoms of migraine headache intended to be alleviated include nausea, unilateral pain, dizziness, pulsatile pain, worsening of pain by light physical activity, photophobia and phonophobia.
REFERENCES:
patent: 2801951 (1957-08-01), Cooper
patent: 3359166 (1967-12-01), McClure
patent: 3385886 (1968-05-01), Nicholson et al.
patent: 3759980 (1973-09-01), Rosen et al.
patent: 3865933 (1975-02-01), Mudge
patent: 4083951 (1978-04-01), Gouldie et al.
patent: 4217340 (1980-08-01), Tobert
patent: 5538959 (1996-07-01), Mauskop
The Pharmacological Basis of Therapeutics, E.D.: Louis Goodman, The MacMillan Company, London, 1970, pp. 988, 989, 813, 316, 354, 359, 368, 315, 325, 326, Oct. 1970.
L.J. Ling et al., "Absorption of Iron After Experimental Overdose of Chewable Vitamins," Am. J. Emerg. Med. 9:24 (1991).
M. Coplin et al., "Tolerability of Iron: A Comparison of Bis-Glycino Iron II and Ferrous Sulfate," Clin. Ther. 13(5):606 (1991).
Goodman & Gilman's The Pharmaceutical Basis of Therapeutics 918, 1317-1325 (Joel G. Hardman et al. eds., 1996).
A.A. Krabbe et al., "Ferrumkvarts som profylaktikum ved migr.ae butted.," Useskr L.ae butted.ger ne 142(8):516-18 (1980) (with English language translation).
J. Olesen et al., "Methodological Aspects of Prophylactic Drug Trials in Migraine," Cephalalgia 1:127-41 (1981).
B.M. Altura, "Calcium Antagonist Properties of Magnesium: Implications for Antimigrane Actions", Magnesium 4:169 (1985).
A. Mauskop et al., "Chronic Daily Headache--One Disease or Two? Diagnostic Role of Serum Ionized Magnesium", Cephalalgia 14:24 (1994).
A. Mauskop et al., "Deficiency in Serum Ionized Magnesium but not Total Magnesium in Patients with Migraines. Possible Role of ICa.sup.2+ /IMg.sup.2+ Ratio", Headache 33(3):135 (1993).
F. Facchinetti et al., "Magnesium Prophylaxis of Menstrual Migraine: Effects on Intacellular Magnesium", Headache 31(5):298 (1991).
K. Weaver, "Magnesium and Migraine", Letter to the Editor in Headache 30(2):168 (1990).
A. Foster et al., "Taking Apart NMDA Receptors", Nature 329: 395-396 (1987) .
Dees Jos,e G.
Shelborne Kathryne E.
LandOfFree
Analgesic composition for treatment of migraine headaches does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analgesic composition for treatment of migraine headaches, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analgesic composition for treatment of migraine headaches will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1707004